Enhancing Value for Patients With Cancer: Time to Treatment as a Surrogate for Integrated Cancer Care
Search for other papers by Brian J. Bolwell in
Current site
Google Scholar
PubMed
Search for other papers by Alok A. Khorana in
Current site
Google Scholar
PubMed
Brian J. Bolwell, MD, is Chairman of the Taussig Cancer Institute of the Cleveland Clinic and responsible for all clinical, financial, academic, operational, professional, and strategic issues pertaining to cancer medicine there. He was Director of the Bone Marrow Transplant Program for 24 years, and Chairman of the Department of Hematologic Oncology & Blood Disorders from 2006 to 2011. He has authored more than 450 articles and abstracts concerning bone marrow transplantation, lymphoma, and other hematologic malignancies; edited or co-edited several textbooks; and serves as ad hoc reviewer for the Journal of Clinical Oncology, Bone Marrow Transplantation, Blood, Annals of Internal Medicine, and many other scientific periodicals. Dr. Bolwell has served as a grant reviewer for the NCI on multiple occasions. He has also served on leadership committees for the ASH and the Center for International Bone Marrow Transplantation Research (CIBMTR).
The ideas and viewpoints expressed in this commentary are those of the author and do not necessarily represent any policy, position, or program of NCCN.
Alok A. Khorana, MD, is Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University; the Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services and Strategy of the Taussig Cancer Institute; and Director of the Gastrointestinal Malignancies Program at the Cleveland Clinic. His clinical and translational research program has been funded by grants from NCI and other institutions.
Dr. Khorana received his MD from Maharaja Sayajirao University's Medical College in India, and his postdoctoral training included a residency at the University at Buffalo and a fellowship at the University of Rochester.
Dr. Khorana is Chair of multiple ASCO panels, including guidelines panels. He is past Chair of the International Society on Thrombosis and Haemostasis Scientific Subcommittee on Hemostasis and Malignancy He has previously served as a member of the US Pharmacopoeia Oncology Expert Committee. Dr. Khorana has been published in a variety of journals, including JAMA and Journal of Clinical Oncology and has coauthored chapters in multiple textbooks.
© 2019-2024 National Comprehensive Cancer Network